Literature DB >> 6852911

Comparison of proteins synthesized by two different isolates of Anaplasma marginale.

A F Barbet, L W Anderson, G H Palmer, T C McGuire.   

Abstract

We present results on the initial definition of proteins synthesized by two isolates of Anaplasma marginale. Bovine erythrocytes infected with A. marginale were radioactively labeled with [35S]methionine or a 3H-amino acid mixture during short-term in vitro culture. The labeled proteins were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. This technique revealed protein bands of various apparent molecular weights from less than 14,000 to greater than 200,000. The bands observed represented A. marginale proteins because (i) uninfected erythrocytes from the same animal did not incorporate radioisotope during identical culture conditions, and (ii) the incorporation of radioisotope into proteins during culture of infected erythrocytes was inhibited by tetracycline but not by cycloheximide. The radioactive protein profiles of two different isolates of A. marginale, from Washington and Florida, were compared by two-dimensional gel electrophoresis. About 200 proteins were resolved in each case. Several proteins differed in position when the two-dimensional gel maps were compared, indicating variations in protein structure between the two A. marginale isolates.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6852911      PMCID: PMC348159          DOI: 10.1128/iai.40.3.1068-1074.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

2.  Finite purification of Anaplasma marginale: serologic inactivity of the anaplasma body.

Authors:  J R Budden; G T Dimopoullos
Journal:  Am J Vet Res       Date:  1977-05       Impact factor: 1.156

3.  An antigenic and serologic comparison of two virulent strains and an attenuated strain of Anaplasma marginale.

Authors:  C A Carson; L G Adams; R A Todorovic
Journal:  Am J Vet Res       Date:  1970-06       Impact factor: 1.156

4.  Cryogenic preservation of Anaplasma marginale with Dimethyl sulfoxide.

Authors:  J N Love
Journal:  Am J Vet Res       Date:  1972-12       Impact factor: 1.156

5.  Neonatal immunohemolytic anemia and icterus of calves.

Authors:  R A Dennis; P J O'Hara; M F Young; K D Dorris
Journal:  J Am Vet Med Assoc       Date:  1970-06-15       Impact factor: 1.936

6.  An attenuated Anaplasma marginale vaccine.

Authors:  M Ristic; S Sibinovic; C J Welter
Journal:  Proc Annu Meet U S Anim Health Assoc       Date:  1968

7.  In vitro incorporation of glycine by bovine erythrocytes infected with Anaplasma marginale.

Authors:  R A Mason; M Ristic
Journal:  J Infect Dis       Date:  1966-06       Impact factor: 5.226

8.  Inhibition of protein synthesis in reticulocytes by antibiotics. I. Effects on polysomes.

Authors:  B Colombo; L Felicetti; C Baglioni
Journal:  Biochim Biophys Acta       Date:  1966-04-18

9.  A study of the immunological relationship of Anaplasma marginale and Anaplasma centrale.

Authors:  K L Kuttler
Journal:  Res Vet Sci       Date:  1967-10       Impact factor: 2.534

10.  The nature of bands in parasitized bovine erythrocytes.

Authors:  C F Simpson; J M Kling; F C Neal
Journal:  J Cell Biol       Date:  1965-10       Impact factor: 10.539

View more
  17 in total

1.  Crossprotective immunity between the Florida and a Zimbabwe stock of Anaplasma marginale.

Authors:  N Tebele; G H Palmer
Journal:  Trop Anim Health Prod       Date:  1991-11       Impact factor: 1.559

2.  Immunization of cattle with the MSP-1 surface protein complex induces protection against a structurally variant Anaplasma marginale isolate.

Authors:  G H Palmer; A F Barbet; G H Cantor; T C McGuire
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

3.  Characterization of an immunoprotective protein complex of Anaplasma marginale by cloning and expression of the gene coding for polypeptide Am105L.

Authors:  A F Barbet; G H Palmer; P J Myler; T C McGuire
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

4.  Evaluation of Anaplasma marginale major surface protein 3 (MSP3) as a diagnostic test antigen.

Authors:  A R Alleman; A F Barbet
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

5.  Monoclonal antibody to a conserved epitope on proteins encoded by Babesia bigemina and present on the surface of intact infected erythrocytes.

Authors:  S Shompole; L E Perryman; F R Rurangirwa; T F McElwain; D P Jasmer; A J Musoke; C W Wells; T C McGuire
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  Expression of major surface protein 2 antigenic variants during acute Anaplasma marginale rickettsemia.

Authors:  G Eid; D M French; A M Lundgren; A F Barbet; T F McElwain; G H Palmer
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

7.  Immunization of cattle with a 36-kilodalton surface protein induces protection against homologous and heterologous Anaplasma marginale challenge.

Authors:  G H Palmer; S M Oberle; A F Barbet; W L Goff; W C Davis; T C McGuire
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

8.  Molecular size variations in an immunoprotective protein complex among isolates of Anaplasma marginale.

Authors:  S M Oberle; G H Palmer; A F Barbet; T C McGuire
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

9.  Expression and immune recognition of the conserved MSP4 outer membrane protein of Anaplasma marginale.

Authors:  S M Oberle; G H Palmer; A F Barbet
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

10.  Presence of common antigens, including major surface protein epitopes, between the cattle (intraerythrocytic) and tick stages of Anaplasma marginale.

Authors:  G H Palmer; K M Kocan; S J Barron; J A Hair; A F Barbet; W C Davis; T C McGuire
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.